Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Blood Loss, Surgical: later-stage trial registry

3 of 7 indexed Blood Loss, Surgical trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Blood Loss, Surgical: 7 US clinical trials tracked, 3 recruiting.

Blood Loss, Surgical is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Ethicon, running 1 of these trials.

Enrollment posture brief

Registry condition blood-loss-surgical

OPEN 3 | RECR 43% | LATE 6 | EARLY 1 | RANK #2497 | SPON 1

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Blood Loss, Surgical (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Blood Loss, Surgical

Blood Loss, Surgical lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Blood Loss, Surgical on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Blood Loss, Surgical is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Blood Loss, Surgical trials is spread across many organizations.

    Ethicon accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Blood Loss, Surgical enrolment sits around 106 participants.

    Median target enrolment is 106 among the 7 trials that report a genuine target (sentinel values excluded). 1 of those (14.3%) plan for fewer than 100 participants.

  4. Blood Loss, Surgical research is mostly interventional.

    7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 32Phase 44

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 2
Phase 4 4

Named interventions

Most-linked intervention names on Blood Loss, Surgical records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
2 trials
Fresh frozen plasma (FFP) Biological
1 trials
Prothrombin complex concentrate (Human) Drug
1 trials
Oxidized Regenerated Cellulose (Surgicel) Device
1 trials
Fibrin Sealant 2 (FS2) Drug
1 trials
Tranexamic Acid 100 MG/ML Drug
1 trials
Tranexamic acid Drug
1 trials
Tranexamic Acid Drug
1 trials

US sites by state

Facility locations filed on Blood Loss, Surgical trials. A trial with sites in several states counts in each.

New York 2 trials
Michigan 2 trials
Massachusetts 2 trials
Virginia 1 trials
Texas 1 trials
Pennsylvania 1 trials
Oregon 1 trials
New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Blood Loss, Surgical page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Blood Loss, Surgical trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Ethicon sponsors the most Blood Loss, Surgical trials on record, review their full trial history before evaluating a specific study. See Ethicon's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blood Loss, Surgical condition card totals 7 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.